TTOO
(NASDAQ)
0.6586
-0.0184  (-2.79%)
Volume (24h): 13.03M Day Range: 0.6500 - 0.7497
Market Cap: 66.36M 52W Range: 0.2350 - 3.28
Mar-26-20 12:48PM Is the Options Market Predicting a Spike in T2 Biosystems (TTOO) Stock?Zacks
Mar-25-20 11:29AM The Daily Biotech Pulse: T2 Biosystems Licenses COVID-19 Test, Immuron CEO Steps DownBenzinga
Mar-24-20 08:31PM T2 Biosystems Announces Worldwide Licensing Agreement of COVID-19, Novel Coronavirus Assay from Hackensack Meridian Health’s Center for Discovery and InnovationGlobeNewswire
08:30PM T2 Biosystems Announces Preliminary First Quarter 2020 Financial ResultsGlobeNewswire
Mar-19-20 12:00PM T2 Biosystems Receives Multiyear Innovative Technology Contract from Vizient, Inc.GlobeNewswire
Mar-10-20 01:48AM Edited Transcript of TTOO earnings conference call or presentation 24-Feb-20 9:30pm GMTThomson Reuters StreetEvents
Mar-09-20 08:41PM Edited Transcript of TTOO earnings conference call or presentation 24-Feb-20 9:30pm GMTThomson Reuters StreetEvents
Mar-07-20 08:35PM Edited Transcript of TTOO earnings conference call or presentation 24-Feb-20 9:30pm GMTThomson Reuters StreetEvents
03:31PM Edited Transcript of TTOO earnings conference call or presentation 24-Feb-20 9:30pm GMTThomson Reuters StreetEvents
Feb-28-20 06:31PM T2 Biosystems, Inc. Analysts Are Cutting Their Estimates: Here's What You Need To KnowSimply Wall St.
Feb-24-20 09:05PM T2 Biosystems Announces Fourth Quarter and Full Year 2019 Financial ResultsGlobeNewswire
Feb-19-20 09:05PM T2 Biosystems to Participate in the SVB Leerink Global Healthcare ConferenceGlobeNewswire
Feb-12-20 09:05PM T2 Biosystems to Report Fourth Quarter and Full Year 2019 Financial Results on February 24, 2020GlobeNewswire
Feb-04-20 02:30PM T2 Biosystems Announces Participation at Clinical Conferences in FebruaryGlobeNewswire
Jan-17-20 09:15PM T2 Biosystems Reports Granting of Inducement AwardGlobeNewswire
Jan-13-20 12:30PM T2 Biosystems Promotes Tony Pare to Chief Commercial OfficerGlobeNewswire
Jan-10-20 12:13PM The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And UltragenyxBenzinga
Jan-09-20 09:30PM T2 Biosystems Announces Preliminary Fourth Quarter 2019 Financial ResultsGlobeNewswire
09:15PM T2 Biosystems Appoints Industry Veteran John Sperzel as Chief Executive OfficerGlobeNewswire
Dec-24-19 01:05AM Is T2 Biosystems Inc (TTOO) Going To Burn These Hedge Funds ?Insider Monkey
Dec-13-19 09:15PM T2 Biosystems Reports Granting of Inducement AwardsGlobeNewswire
Nov-29-19 01:52PM Edited Transcript of TTOO earnings conference call or presentation 12-Nov-19 1:30pm GMTThomson Reuters StreetEvents
Nov-21-19 05:21AM Edited Transcript of TTOO earnings conference call or presentation 12-Nov-19 1:30pm GMTThomson Reuters StreetEvents
Nov-20-19 12:30PM T2 Biosystems Announces Granting of CE-Mark for T2Resistance™ PanelGlobeNewswire
Nov-15-19 12:30PM T2 Biosystems to Present at the 13th Annual Canaccord Genuity Medical Technology & Diagnostics ForumGlobeNewswire
Nov-13-19 02:06AM Edited Transcript of TTOO earnings conference call or presentation 12-Nov-19 1:30pm GMTThomson Reuters StreetEvents
Nov-12-19 12:30PM T2 Biosystems Reports Third Quarter 2019 Financial Highlights and Provides Corporate UpdateGlobeNewswire
Nov-08-19 09:15PM T2 Biosystems Reports Granting of Inducement AwardsGlobeNewswire
Nov-07-19 12:30PM T2 Biosystems to Share Early Data at the World Anti-Microbial Resistance Congress (November 7-8, 2019)GlobeNewswire
11:08AM These 36 Mass. firms made Deloitte's Technology Fast 500American City Business Journals
Nov-05-19 03:33PM Analysts Estimate T2 Biosystems (TTOO) to Report a Decline in Earnings: What to Look Out forZacks
Oct-31-19 08:15PM T2 Biosystems Announces 2019 Third Quarter Financial and Operational Results Release and Conference Call DateGlobeNewswire
02:34PM Earnings Preview: T2 Biosystems (TTOO) Q3 Earnings Expected to DeclineZacks
Oct-11-19 11:30AM T2 Biosystems Reports Granting of Inducement AwardsGlobeNewswire
Oct-09-19 06:13PM Introducing T2 Biosystems (NASDAQ:TTOO), The Stock That Tanked 84%Simply Wall St.
Oct-02-19 11:30AM T2 Biosystems to Showcase Latest Innovations at IDWeek 2019GlobeNewswire
Sep-30-19 11:30AM T2 Biosystems’ T2Resistance™ Panel is Now Available as a Research Use Only (RUO) Test in the U.S.GlobeNewswire
Sep-26-19 08:15PM T2 Biosystems to Present at the 2019 Cantor Global Healthcare ConferenceGlobeNewswire
Sep-25-19 11:30AM T2 Biosystems Enters into Distribution Agreement to Expand its Innovative Rapid Diagnostic Technologies to Puerto Rico and the U.S. Virgin IslandsGlobeNewswire
Sep-24-19 11:00AM T2 Biosystems’ T2Resistance™ Panel is First Diagnostic to Graduate from CARB-X PortfolioGlobeNewswire
Sep-19-19 11:30AM T2 Biosystems Reports Granting of Inducement AwardsGlobeNewswire
Sep-13-19 08:39AM 2 Downtrodden Small Biotechs That Are Showing Signs of LifeTheStreet.com
Sep-11-19 01:30PM T2 Biosystems Receives Funding from BARDA to Advance Technology for Diagnosis and Treatment of Bloodstream InfectionsGlobeNewswire
Sep-10-19 08:21PM T2 Biosystems to Host Conference Call to Discuss Awarding of Multi-Million Dollar BARDA ContractGlobeNewswire
08:14PM T2 Biosystems Announces Restructuring of CRG Term Loan AgreementGlobeNewswire
Sep-10-19 08:05PM T2 Biosystems Awarded Breakthrough Technology Contract with Premier Inc.GlobeNewswire
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States. It provides T2 Magnetic Resonance platform that enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, and urine. The company also offers T2Dx, a bench-top instrument for sepsis, Lyme disease, and other applications, as well as T2Candida panel for the detection of candida species in human whole blood specimens. In addition, it is developing T2Bacteria, a multiplex diagnostic panel that detects various bacterial pathogens associated with sepsis; T2Lyme for the detection of various strains of Lyme disease-causing bacteria; and T2Plex, an integrated instrument for hemostasis applications. The company has collaboration agreement with Canon U.S. Life Sciences, Inc. to develop a novel diagnostic test panel to detect Lyme disease; and Allergan Sales, LLC for the direct detection diagnostic test panel that adds additional bacteria species to the existing T2Bacteria product candidate and testing drug resistance directly in whole blood. T2 Biosystems, Inc. was founded in 2006 and is headquartered in Lexington, Massachusetts.
Stocks in other countries: United Kingdom India Canada Australia
Market Cap
Volume (24h)